These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 28511189

  • 1. The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer.
    Caballero M, Mackers P, Reig O, Buxo E, Navarrete P, Blanch JL, Grau JJ.
    Oncology; 2017; 93(2):75-82. PubMed ID: 28511189
    [Abstract] [Full Text] [Related]

  • 2. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT.
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250
    [Abstract] [Full Text] [Related]

  • 3. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA.
    Audiol Neurootol; 2006 Sep; 11(5):318-30. PubMed ID: 16983183
    [Abstract] [Full Text] [Related]

  • 4. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.
    van der Hulst RJ, Dreschler WA, Urbanus NA.
    Ann Otol Rhinol Laryngol; 1988 Sep; 97(2 Pt 1):133-7. PubMed ID: 3281541
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V, Meyer F, Guitton MJ, Bussières R, Philippon D, Bairati I, Leclerc M, Côté M.
    J Otolaryngol Head Neck Surg; 2019 Jan 16; 48(1):4. PubMed ID: 30651130
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
    Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB.
    J Clin Oncol; 2016 Aug 10; 34(23):2712-20. PubMed ID: 27354478
    [Abstract] [Full Text] [Related]

  • 7. The importance of high-tone audiometry in monitoring for ototoxicity.
    Tange RA, Dreschler WA, van der Hulst RJ.
    Arch Otorhinolaryngol; 1985 Aug 10; 242(1):77-81. PubMed ID: 3899068
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec 10; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 9. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819
    [Abstract] [Full Text] [Related]

  • 10. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ, Martin K, Abab J, Ratcliffe I, Thornton R, Lineton B, Ellis M, Moody R, Stanton L, Galanopoulou A, Maishman T, Geldart T, Bayne M, Davies J, Lamb C, Popat S, Joffe JK, Nutting C, Chester J, Hartley A, Thomas G, Ottensmeier C, Huddart R, King E.
    Eur J Cancer; 2017 Dec 01; 87():75-83. PubMed ID: 29128692
    [Abstract] [Full Text] [Related]

  • 11. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Schornagel JH, Dreschler WA, Rasch CR, Balm AJ.
    J Clin Oncol; 2007 Aug 20; 25(24):3759-65. PubMed ID: 17704425
    [Abstract] [Full Text] [Related]

  • 12. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer.
    Schuette A, Lander DP, Kallogjeri D, Collopy C, Goddu S, Wildes TM, Daly M, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2020 Feb 01; 146(2):106-112. PubMed ID: 31750863
    [Abstract] [Full Text] [Related]

  • 13. Development and validation of a cisplatin dose-ototoxicity model.
    Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D.
    J Am Acad Audiol; 2012 Feb 01; 23(7):510-21. PubMed ID: 22992258
    [Abstract] [Full Text] [Related]

  • 14. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Verkaik RS, Schornagel JH, Balm AJ, Dreschler WA, Rasch CR.
    Radiother Oncol; 2008 Oct 01; 89(1):38-43. PubMed ID: 18706728
    [Abstract] [Full Text] [Related]

  • 15. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL.
    Med Pediatr Oncol; 1996 Feb 01; 26(2):95-100. PubMed ID: 8531860
    [Abstract] [Full Text] [Related]

  • 16. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
    Deutsch BC, Collopy C, Kallogjeri D, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2021 Feb 01; 147(2):182-189. PubMed ID: 33300954
    [Abstract] [Full Text] [Related]

  • 17. The role of ultrahigh-frequency audiometry in the early detection of systemic drug-induced hearing loss.
    Singh Chauhan R, Saxena RK, Varshey S.
    Ear Nose Throat J; 2011 May 01; 90(5):218-22. PubMed ID: 21563089
    [Abstract] [Full Text] [Related]

  • 18. Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.
    Kalyanam B, Sarala N, Azeem Mohiyuddin SM, Diwakar R.
    J Cancer Res Ther; 2018 May 01; 14(5):1099-1104. PubMed ID: 30197356
    [Abstract] [Full Text] [Related]

  • 19. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A.
    Acta Otolaryngol; 2021 Sep 01; 141(9):885-893. PubMed ID: 34486907
    [Abstract] [Full Text] [Related]

  • 20. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity?
    Schultz C, Pecora Liberman PH, Schmidt Goffi-Gomez MV.
    Audiol Neurootol; 2019 Sep 01; 24(5):253-257. PubMed ID: 31661686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.